Document is current
Any future updates will be listed below
-
Authors
Ferrández, Maria C.
Golla, Sandeep S. V.
Eertink, Jakoba J.
de Vries, Bart M.
Lugtenburg, Pieternella J.
Wiegers, Sanne E.
Zwezerijnen, Gerben J. C.
Pieplenbosch, Simone
Kurch, Lars
Hüttmann, Andreas
Hanoun, Christine
Dührsen, Ulrich
de Vet, Henrica C. W.
,
Hoekstra, Otto S.
Burggraaff, Coreline N.
Bes, Annelies
Heymans, Martijn W.
Jauw, Yvonne W. S.
Chamuleau, Martine E. D.
Barrington, Sally F.
Mikhaeel, George
Zucca, Emanuele
Ceriani, Luca
Carr, Robert
Györke, Tamás
Czibor, Sándor
Fanti, Stefano
Kostakoglu, Lale
Loft, Annika
Hutchings, Martin
Lee, Sze Ting
Zijlstra, Josée M.
Boellaard, Ronald
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (VU-2018-11648, VU-2018-11648)
Hanarth Fonds
- License Information
-
More Information
Article History
Received: 31 March 2023
Accepted: 7 August 2023
First Online: 12 August 2023
Competing interests
: This work was financially supported by the Hanarth Fonds Fund and the Dutch Cancer Society (#VU-2018-11648). M.C.F., S.S.V.G, J.J.E., B.M.d.V., S.E.W., G.J.C.Z., S.P., L.K., A.H., C.H., U.D., H.C.W.d.V. and R.B. declare no competing financial interests. P.J.L. received research funding from Takeda, Servier and Roche and received honoraria for advisory boards from Takeda, Servier, Genentech, Genmab, Celgene, Incyte and AbbVie. J.M.Z. received research funding from Roche and received honoraria for advisory boards from Takeda, Gilead, BMS and Roche. No other potential conflicts of interest relevant to this article exist.
